Loading…

ENDATA · Copyright (c) 2026 Endata · Data: CEPII BACI (Etalab 2.0), Federal Reserve G.17, U.S. BLS, Eurostat, World Bank (CC BY 4.0), GLEIF, SEC EDGAR; announcements summarized from the linked sourcesProspects Companies Sectors Announcements Countries

HOME BRIEF PROSPECTS SECTORS ANNOUNCEMENTS COMPANIES COUNTRIES

>

INDUSTRIAL MARKET INTELLIGENCE

INDUSTRIAL MACHINERY273.5▲ +4.87%AUTOMATION AND ROBOTICS348.5▲ +10.05%PUMPS AND VALVES401.5▲ +2.64%MATERIAL HANDLING340.7▲ +3.73%FOOD PROCESSING EQUIPMENT394.8▲ +4.07%STEEL AND METAL PRODUCTS344.9▲ +29.04%SPECIALTY CHEMICALS256.3▲ +5.14%PLASTICS AND POLYMERS327.5▲ +5.94%PACKAGING506.1▲ +8.86%INDUSTRIAL TEXTILES185.9▲ +3.45%ELECTRICAL EQUIPMENT256.3▲ +8.77%SEMICONDUCTORS AND INDUSTRIAL ELECTRONICS75.3▲ +26.02%AUTOMOTIVE COMPONENTS134.7▲ +3.13%AEROSPACE COMPONENTS291.0▲ +2.38%MEDICAL DEVICES146.2▲ +4.99%CONSTRUCTION MATERIALS262.9▲ +4.08%HVAC AND INDUSTRIAL REFRIGERATION243.3▲ +5.55%POWER GENERATION EQUIPMENT289.6▲ +3.63%WATER TREATMENT EQUIPMENT152.1▲ +2.68%MINING EQUIPMENT462.3▲ +3.56%INDUSTRIAL MACHINERY273.5▲ +4.87%AUTOMATION AND ROBOTICS348.5▲ +10.05%PUMPS AND VALVES401.5▲ +2.64%MATERIAL HANDLING340.7▲ +3.73%FOOD PROCESSING EQUIPMENT394.8▲ +4.07%STEEL AND METAL PRODUCTS344.9▲ +29.04%SPECIALTY CHEMICALS256.3▲ +5.14%PLASTICS AND POLYMERS327.5▲ +5.94%PACKAGING506.1▲ +8.86%INDUSTRIAL TEXTILES185.9▲ +3.45%ELECTRICAL EQUIPMENT256.3▲ +8.77%SEMICONDUCTORS AND INDUSTRIAL ELECTRONICS75.3▲ +26.02%AUTOMOTIVE COMPONENTS134.7▲ +3.13%AEROSPACE COMPONENTS291.0▲ +2.38%MEDICAL DEVICES146.2▲ +4.99%CONSTRUCTION MATERIALS262.9▲ +4.08%HVAC AND INDUSTRIAL REFRIGERATION243.3▲ +5.55%POWER GENERATION EQUIPMENT289.6▲ +3.63%WATER TREATMENT EQUIPMENT152.1▲ +2.68%MINING EQUIPMENT462.3▲ +3.56%

CGBIO: plants, expansions, contracts and acquisitions · Endata

CGBIO

South Korea MEDICAL DEVICES

Activity by year

2

1

20192020202120222023202420252026

Contract

Announcements · 3

Sep 16, 2020CONTRACTAustralia and New Zealand, Australia
CGBIO to supply NOVOSIS to LifeHealthcare in Australia
CGBIO announced an agreement with LifeHealthcare to supply its rhBMP-2 bone graft product NOVOSIS for the Australian and New Zealand markets, with potential revenue of KRW 200 billion.
LifeHealthcare Group Limited customer CGBIO supplier #Medical Devices cgbio.co.kr
Sep 18, 2019CONTRACTJapan$500.0M
CGBIO signs $500M deal with Japan's Nippon Zoki for Novosis Putty
South Korean biopharmaceutical firm CGBIO signed an exclusive agreement worth $500 million with Japan's Nippon Zoki Pharmaceutical to develop and commercialize Novosis Putty, a bone graft treatment for lumbar spine degeneration.
CGBIO Nippon Zoki Pharmaceutical partner #Medical Devices cgbio.co.kr
Sep 9, 2019CONTRACTIndia$30.0M
CGBIO signs $30M supply deal with India's Eris Lifesciences for Novosis
South Korean medical device company CGBIO signed a $30 million supply contract with India's Eris Lifesciences for its bone graft product Novosis. The deal covers the Indian market.
CGBIO Eris Lifesciences customer #Medical Devices cgbio.co.kr

Dealingsⓘ

Customers

LifeHealthcare Group Limited2020
Eris Lifesciences2019

Partners

Nippon Zoki Pharmaceutical2019

Home market · South Koreaⓘ

Medical Devicesimports

Medical Devicesexports

Similar companiesⓘ

ASTASouth Korea
CelltrionSouth Korea
DmedSouth Korea
D.medSouth Korea
GC Green Cross WellbeingSouth Korea
GC WellbeingSouth Korea
OSTEONICSouth Korea

3HSouth Korea

ATGenSouth Korea

BioneerSouth Korea